13D/13G Filings - AKCEA THERAPEUTICS INC. (AKCA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-11-10
10:27 am
Sale
2020-11-0913GAKCEA THERAPEUTICS INC
AKCA
FMR LLC0
0.000%
-5,716,836decrease
(Position Closed)
Filing
History
2020-10-13
10:35 am
Sale
2020-10-1213GAKCEA THERAPEUTICS INC
AKCA
FMR LLC5,716,836
5.625%
-5,079,303decrease
(-47.05%)
Filing
History
2020-10-13
08:47 am
Sale
2020-10-1013DAKCEA THERAPEUTICS INC
AKCA
IONIS PHARMACEUTICALS INC
IONS
1,000
100.000%
-77,093,682decrease
(-100.00%)
Filing
History
2020-08-31
07:12 am
Unchanged
2020-08-3013DAKCEA THERAPEUTICS INC
AKCA
IONIS PHARMACEUTICALS INC
IONS
77,094,682
75.900%
0
(Unchanged)
Filing
History
2020-02-07
11:12 am
Sale
2020-02-0613GAKCEA THERAPEUTICS INC
AKCA
FMR LLC10,796,139
11.497%
-2,585,367decrease
(-19.32%)
Filing
History